These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25548719)

  • 1. Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats.
    Lee JC; Kim KC; Yang YS; Oh W; Choi SJ; Choe SY; Hong YM
    Anat Cell Biol; 2014 Dec; 47(4):217-26. PubMed ID: 25548719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis after adipose derived mesenchymal stem cells injection in monosodium iodoacetate-induced osteoarthritis rats.
    Lee JC
    Genes Genomics; 2018 Jan; 40(1):25-37. PubMed ID: 29892899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray.
    Jeong JA; Hong SH; Gang EJ; Ahn C; Hwang SH; Yang IH; Han H; Kim H
    Stem Cells; 2005 Apr; 23(4):584-93. PubMed ID: 15790779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Oh S; Jang AY; Chae S; Choi S; Moon J; Kim M; Spiekerkoetter E; Zamanian RT; Yang PC; Hwang D; Byun K; Chung WJ
    Sci Rep; 2021 Jan; 11(1):2012. PubMed ID: 33479312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Lee H; Kim KC; Choi SJ; Hong YM
    Yonsei Med J; 2017 May; 58(3):570-580. PubMed ID: 28332363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration.
    Hei WH; Almansoori AA; Sung MA; Ju KW; Seo N; Lee SH; Kim BJ; Kim SM; Jahng JW; He H; Lee JH
    Neurosci Lett; 2017 Mar; 643():111-120. PubMed ID: 28215880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
    Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
    Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice.
    Yim YS; Noh YH; Kim DH; Lee MW; Cheuh HW; Lee SH; Yoo KH; Jung HL; Sung KW; Choi SJ; Oh WI; Yang YS; Koo HH
    Transplant Proc; 2010 Sep; 42(7):2753-8. PubMed ID: 20832581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood mesenchymal stem cells expansion via human fibroblast-derived matrix and their potentials toward regenerative application.
    Van SY; Noh YK; Kim SW; Oh YM; Kim IH; Park K
    Cell Tissue Res; 2019 May; 376(2):233-245. PubMed ID: 30610451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble PTX3 of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuates Hyperoxic Lung Injury by Activating Macrophage Polarization in Neonatal Rat Model.
    Kim M; Kwon JH; Bae YK; Kim GH; Um S; Ha J; Choi SJ; Oh W; Jin HJ
    Stem Cells Int; 2020; 2020():1802976. PubMed ID: 32399038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IMMUNOGENICITY OF HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS AFTER OSTEOGENIC INDUCTION].
    Yang D; Lin H; Liu G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):752-7. PubMed ID: 26455231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
    Bougioukli S; Saitta B; Sugiyama O; Tang AH; Elphingstone J; Evseenko D; Lieberman JR
    Hum Gene Ther; 2019 Jul; 30(7):906-917. PubMed ID: 30773946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow.
    Hua J; Gong J; Meng H; Xu B; Yao L; Qian M; He Z; Zou S; Zhou B; Song Z
    Cell Biol Int; 2013 Oct; ():. PubMed ID: 24123669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro.
    Hu YH; Wu DQ; Gao F; Li GD; Zhang XC
    Chin Med J (Engl); 2010 Mar; 123(5):606-14. PubMed ID: 20367990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.